EFFECTS OF ABATACEPT ON MONOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:2
|
作者
Bonelli, M. [1 ]
Ferner, E. [1 ]
Savitskaya, A. [1 ]
Blueml, S. [1 ]
Steiner, C-W [1 ]
Rath, E. [1 ]
Smolen, J. S. [1 ]
Scheinecker, C. [1 ]
机构
[1] Med Univ Vienna, Vienna, Austria
关键词
D O I
10.1136/ard.2010.129668f
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A169
引用
收藏
页码:A67 / A67
页数:1
相关论文
共 50 条
  • [41] Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis
    Silvia Piantoni
    Enrico Colombo
    Angela Tincani
    Paolo Airò
    Mirko Scarsi
    Clinical Rheumatology, 2016, 35 : 1065 - 1069
  • [42] Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
    Waka Yokoyama-Kokuryo
    Hayato Yamazaki
    Tsutomu Takeuchi
    Koichi Amano
    Jun Kikuchi
    Tsuneo Kondo
    Seiji Nakamura
    Ryoko Sakai
    Fumio Hirano
    Toshihiro Nanki
    Ryuji Koike
    Masayoshi Harigai
    Arthritis Research & Therapy, 22
  • [43] PREDICTORS OF RESPONSE TO TREATMENT WITH ABATACEPT IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS
    Fazi, S.
    Picchianti, A.
    Podesta, E.
    Markovic, M.
    Lagana, B.
    D'Amelio, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 204 - 204
  • [44] Predictive Factors of Persistence in Therapy with Abatacept in Patients with Rheumatoid Arthritis
    Piantoni, Silvia
    Colombo, Enrico
    Tincani, Angela
    Airo, Paolo
    Scarsi, Mirko
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] RESULTS OF ABATACEPT TREATMENT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
    Kanonirova, M. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Glukhova, S. I.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A59 - +
  • [46] COMPARISON OF THE EFFICACY OF ABATACEPT ON ELDERLY AND YOUNG PATIENTS WITH RHEUMATOID ARTHRITIS
    Muraoka, S.
    Yamada, Z.
    Hirose, W.
    Kono, H.
    Yasuda, S.
    Nanki, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 988 - 988
  • [47] Abatacept: A novel therapy approved for the treatment of patients with rheumatoid arthritis
    Lundquist, Lisa
    ADVANCES IN THERAPY, 2007, 24 (02) : 333 - 345
  • [48] Long-term safety of abatacept in patients with rheumatoid arthritis
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Mutti, Alessandra
    Bugatti, Serena
    Cavagna, Lorenzo
    Caporali, Roberto
    AUTOIMMUNITY REVIEWS, 2013, 12 (12) : 1115 - 1117
  • [49] GLUCOCORTICOID-SPARING EFFECTS OF ABATACEPT IN RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH BOTH ABATACEPT EFFECTIVENESS AND SEROPOSITIVITY
    Gottenberg, J. -E.
    Courvoisier, D.
    Hetland, M.
    Turesson, C.
    Canhao, H.
    Hernandez, M. V.
    Iannone, F.
    Lie, E.
    Pavelka, K.
    Choquette, D.
    Mariette, X.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 967 - 967
  • [50] Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
    Rubbert-Roth, Andrea
    Enejosa, Jeffrey
    Pangan, Aileen L.
    Haraoui, Boulos
    Rischmueller, Maureen
    Khan, Nasser
    Zhang, Ying
    Martin, Naomi
    Xavier, Ricardo M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (16): : 1511 - 1521